BioCrossroads Celebrates 20 Year Milestone

BioCrossroads, the state's initiative to grow and invest in life sciences, is marking 20 years since its launch. The public-private collaboration has supported the state's existing research and corporate strengths, while encouraging new business development through three venture capital funds and more than 500 startups.... Read More

Purdue Professor Granted $1M for Swine Fever Test

A team of Purdue University researchers are working to develop a rapid, pen-side test for African swine fever, a highly contagious swine disease in the Dominican Republic. Mohit Verma, assistant professor of agricultural and biological engineering at Purdue, has been awarded a $1 million grant for the project.... Read More

Record Revenue Helps OrthoPediatrics Narrow Loss

Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) is reporting a full-year net loss of $16.2 million in 2021, compared to a loss of $33 million the previous year. Despite the loss, the pediatric orthopedic device manufacturer says it hit record annual revenue of $98 million.... Read More

Lilly Drug Gains Additional FDA Approval

The U.S. Food and Drug Administration has awarded another approval for Jardiance developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Boehringer Ingelheim in Germany. The company says Jardiance has been approved to treat adults with any type of heart failure.... Read More

$34M Gift Launches Youth Psych Center, Attracts Researcher to Evansville

One of the largest gifts in Indiana University School of Medicine (IUSM) history will address what local medical experts call a desperate shortage of care in the Evansville region—youth mental health. Evansville natives Bill and Mary O’Daniel Stone recently gifted the school $34 million to create the Stone Center for Child and Adolescent Psychiatry. IUSM […]... Read More

Pharma Leads $500 Million Investment Total in 2021

While the pandemic provided a business backdrop unlike any other in history, Indiana’s life sciences industry saw “extraordinary” growth in 2021, says the Indiana Economic Development Corp. Twenty-three life sciences companies in the state committed to investing over $500 million in 2021, and the pharmaceutical sector led the charge, accounting for $381 million of that […]... Read More

Lumavate Raises $6M to ‘Make Everyone an App Builder’

Lumavate’s line of work is still a surprise to many business leaders, says Chief Executive Officer Stephanie Cox. The Carmel-based tech startup, which recently closed a $6 million funding round, helps businesses build their own apps—no need to know code or use an IT developer—and “still a large number of people don’t even know that’s […]... Read More

Drug to Reverse Anesthesia Complication Tests in Patients Soon

While emerging from general anesthesia may seem a straightforward process, helping patients—both healthy and with complications—to “Open Your Eyes” is the mission of OYE Therapeutics. Delayed emergence from anesthesia is costly to both the patient and the healthcare system; one study showed the condition causes 32,000 deaths each year and $9.3 billion annually in added […]... Read More

Purdue Life Sciences Company Receives NSF Grant

A life sciences company based out of a Purdue University professor’s lab has received a nearly $975,000 Small Business Innovation Research grant from the National Science Foundation. GeniPhys says it will use the two-year grant to scale up manufacturing capabilities to commercialize its initial product.... Read More

BioCrossroads Celebrates Life Sciences Growth

life sciences industry saw strong growth last year, particularly in the pharmaceutical and medical device sectors. The state's life sciences initiative says 23 companies committed to invest more than $500 million and add 2,100 employees in Indiana. ... Read More

Telix FDA Approval Strengthens Radiopharma in Indy

Industry experts say Indiana is emerging as a powerful hub for nuclear medicine, and the most recent fuel to be added to the fire is Telix Pharmaceuticals earning approval from the U.S. Food and Drug Administration to launch its first commercial product. The radiopharmaceuticals sector, also known as nuclear medicine, is gathering momentum in central […]... Read More

High School Students Uncover New DNA Sequences

A recent DNA discovery means four Hoosier high school students are published scientists at the young age of 18. While COVID wreaked havoc on students’ senior years, Noblesville High School teacher Caitlyn Foye got creative with the closures and brought cutting-edge research to her classroom. The students uncovered four new gene sequences—a discovery so rare […]... Read More

IU Discoveries, New Trial Build Hope for Aggressive Breast Cancer

Triple negative breast cancer (TNBC) is a devastating form of breast cancer that has left researchers scrambling to find weapons against its high recurrence rate, lower survival rate than other forms of the disease and confusion about how to best treat it—and Indiana is leading the charge. As a nerve center for TNBC research, the […]... Read More

Paradigm Shift in Depression Treatment Inspires Startup

In the same way that precision medicine has revolutionized the treatment of cancer, it could also radically improve how patients are treated for depression, says Carmel-based startup Gate Neurosciences Inc. In oncology, precision medicine enables doctors to analyze the biology of the patient’s tumor, then prescribe drugs that are most powerful against that specific type […]... Read More

Study: Cook Medical Plant to Bring Big Impact

Indiana University’s Public Policy Institute is estimating the Cook Medical manufacturing facility under construction on the northeast side of Indianapolis will have an economic impact of nearly $26 million annually for Marion County.... Read More

Apria to be Acquired in $1.6B Deal

An Indianapolis-based home healthcare equipment provider will soon be under new ownership less than a year after going public. Virginia-based Owens & Minor Inc. (NYSE: OMI) has entered into a definitive agreement to acquire Apria Inc. (Nasdaq: APR) in a deal valued at $1.6 billion. Owens & Minor says the acquisition will position the company as a leader in the home healthcare market.... Read More

Lilly Partnering with Canadian Pharma Company

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research and collaboration agreement with Entos Pharmaceuticals in Canada. Lilly says the deal will support the development of therapies for multiple neurologic conditions.... Read More

Merck to Acquire Indy Company in $780M Deal

A Hoosier biopharmaceutical contract development and manufacturing organization will soon be under new ownership. Germany-based Merck KGaA has announced plans to acquire Exelead, headquartered in Indianapolis, in a $780 million deal. Merck ... Read More